How to use this document
Copy the template below into your quality system. Replace every <<FILL: ...>> placeholder with your company, system, and process specifics, then route it through your own document control, review, and approval. The filled specimen shows one worked example; adapt the numbers and scope to your operation and verify each cited regulation or standard against the current source before you rely on it.
This is a generic, originally worded starting point. It contains no confidential, proprietary, or employer material, it is drafted with AI assistance and reviewed, it is not legal or compliance advice, and adopting it does not by itself create or prove compliance. See the Disclaimer and Terms.
This is a ready-to-use plan for agreeing, before a real CCIT failure happens, the sequence used to decide whether a borderline or failing result is a true leak or a test artifact. Complete it during method validation or CCIT protocol drafting so the investigation logic exists before anyone is deciding under schedule pressure with a real result and a batch sitting in the warehouse. Replace every <<FILL: ...>> placeholder with your own specifics and route it through your normal document control, review, and approval. A worked filled specimen follows.
1. Purpose
This plan states, with a pre-agreed sequence, how a borderline or failing CCIT result is investigated before it is classified as a true leak or as a test artifact, and what happens to the result, and to units tested around it, at each step of that sequence.
2. Scope
3. Responsibilities
4. Artifact-check sequence
Work these checks in order for every borderline or failing result. Do not skip ahead to a retest before the earlier checks are documented.
5. Decision rule
The sequence in section 4 is not an opportunity to propose a plausible-sounding explanation and stop; every step claimed as the cause has to carry documented evidence, not an assertion.
6. Escalation and documentation
7. Conclusion
8. References
USP General Chapter <1207>, Package Integrity Evaluation, General Considerations.
21 CFR 211.192, review and investigation of an unexplained discrepancy.
See the paired article, building a container closure integrity program under USP <1207>, for the reasoning behind this sequence and the specific CCIT artifact sources it addresses.
The paired CCIT system suitability verification log for the bracketing evidence step 1 relies on.
9. Revision history
10. Approvals
Filled specimen
Extract for a vacuum decay CCIT method on a lyophilized biologic vial, validated method permitting one pre-authorized retest per unit under confirmed-correct conditions.
A stability-pull unit read a pressure rise just past the acceptance threshold. Working the sequence: step 1, the system suitability bracket on either side of this unit both passed, ruling out an instrument-wide cause; step 2, fixture seating was not applicable (rigid vial, no restraint fixture); step 3, the unit had been removed from 2 to 8 degrees C storage and tested 4 minutes after removal, short of the method’s 15-minute equilibration requirement; step 4, no visible condensation was noted but was not separately documented at the time, a gap flagged for the method’s retest record going forward. The unit was re-equilibrated for the full 15 minutes and retested: the repeat result passed well inside the acceptance range. Classification: artifact, incomplete thermal equilibration, confirmed by documented equilibration time and a passing retest; original result voided per this plan, unit released on the retest result. QA approval cited step 3 as the specific resolving evidence.
Common inspection findings this plan prevents
- A borderline result dispositioned as passing on a proposed artifact, residual moisture or a cold unit, that was never actually confirmed with documented evidence.
- A retest performed with no pre-authorization in the validated method, amounting to an undocumented quiet retest.
- An investigation sequence invented in the moment rather than worked against a pre-agreed order, producing inconsistent classifications for similar results over time.
- A genuinely ambiguous result resolved in the direction that avoids an investigation rather than the conservative default.
How to adapt this plan
- Confirm in section 2 whether your validated method actually pre-authorizes a retest; if it does not, strike step 5 and route every borderline or failing result directly to deviation or OOS investigation.
- Set the artifact-check sequence in section 4 to match this specific method’s real failure modes; a method with no fixture, for example, can remove step 2 rather than carry an inapplicable row.
- Train CCIT operators on the sequence before a real failure happens, not as a procedure read for the first time during one.
- Route every classification through Quality Assurance approval; never let an artifact classification stand on the operator’s or SME’s documentation alone.